##gff-version 3
##sequence-region P08588 1 477
P08588	UniProtKB	Chain	1	477	.	.	.	ID=PRO_0000069118;Note=Beta-1 adrenergic receptor	
P08588	UniProtKB	Topological domain	1	55	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Transmembrane	56	84	.	.	.	Note=Helical%3B Name%3D1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Topological domain	85	93	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Transmembrane	94	120	.	.	.	Note=Helical%3B Name%3D2;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Topological domain	121	132	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Transmembrane	133	154	.	.	.	Note=Helical%3B Name%3D3;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Topological domain	155	172	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Transmembrane	173	196	.	.	.	Note=Helical%3B Name%3D4;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Topological domain	197	222	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Transmembrane	223	248	.	.	.	Note=Helical%3B Name%3D5;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Topological domain	249	319	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Transmembrane	320	349	.	.	.	Note=Helical%3B Name%3D6;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Topological domain	350	354	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Transmembrane	355	377	.	.	.	Note=Helical%3B Name%3D7;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Topological domain	378	477	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Region	218	232	.	.	.	Note=Agonist and antagonist binding;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Region	337	344	.	.	.	Note=Agonist and antagonist binding;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Region	363	367	.	.	.	Note=Agonist and antagonist binding;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Motif	474	477	.	.	.	Note=PDZ-Binding	
P08588	UniProtKB	Binding site	138	138	.	.	.	Note=Agonist or antagonist;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Binding site	143	143	.	.	.	Note=Agonist or antagonist;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Modified residue	312	312	.	.	.	Note=Phosphoserine%3B by PKA;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P08588	UniProtKB	Modified residue	412	412	.	.	.	Note=Phosphoserine%3B by PKA;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P08588	UniProtKB	Modified residue	428	428	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P18090	
P08588	UniProtKB	Lipidation	392	392	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08588	UniProtKB	Glycosylation	15	15	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08588	UniProtKB	Disulfide bond	131	216	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00521	
P08588	UniProtKB	Disulfide bond	209	215	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00521	
P08588	UniProtKB	Natural variant	26	26	.	.	.	ID=VAR_055909;Note=A->V;Dbxref=dbSNP:rs34844626	
P08588	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_055910;Note=A->T;Dbxref=dbSNP:rs35720093	
P08588	UniProtKB	Natural variant	31	31	.	.	.	ID=VAR_055911;Note=R->Q;Dbxref=dbSNP:rs35230616	
P08588	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_009879;Note=Associated with high mean resting heart rate. S->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10477438,ECO:0000269|PubMed:11052857,ECO:0000269|PubMed:11854867,ECO:0000269|Ref.3;Dbxref=dbSNP:rs1801252,PMID:10477438,PMID:11052857,PMID:11854867	
P08588	UniProtKB	Natural variant	389	389	.	.	.	ID=VAR_009880;Note=Reduced binding to G proteins. R->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10212248,ECO:0000269|PubMed:10477438,ECO:0000269|PubMed:15164054,ECO:0000269|Ref.3;Dbxref=dbSNP:rs1801253,PMID:10212248,PMID:10477438,PMID:15164054	
P08588	UniProtKB	Natural variant	389	389	.	.	.	ID=VAR_018742;Note=R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.3	
P08588	UniProtKB	Natural variant	399	399	.	.	.	ID=VAR_055912;Note=R->H;Dbxref=dbSNP:rs36052953	
P08588	UniProtKB	Natural variant	405	405	.	.	.	ID=VAR_055913;Note=H->Y;Dbxref=dbSNP:rs35705839	
P08588	UniProtKB	Mutagenesis	474	474	.	.	.	Note=Loss of interaction with GOPC. E->A%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15358775;Dbxref=PMID:15358775	
P08588	UniProtKB	Mutagenesis	474	474	.	.	.	Note=Loss of interaction with GOPC%3B when associated with A-477. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15358775;Dbxref=PMID:15358775	
P08588	UniProtKB	Mutagenesis	475	475	.	.	.	Note=Loss of interaction with GOPC. Loss of interaction with RAPGEF2. Abolishes agonist-induced Ras activation. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12391161,ECO:0000269|PubMed:15358775;Dbxref=PMID:12391161,PMID:15358775	
P08588	UniProtKB	Mutagenesis	475	475	.	.	.	Note=Loss of interaction with RAPGEF2. S->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12391161,ECO:0000269|PubMed:15358775;Dbxref=PMID:12391161,PMID:15358775	
P08588	UniProtKB	Mutagenesis	475	475	.	.	.	Note=Partial loss of interaction with GOPC. S->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12391161,ECO:0000269|PubMed:15358775;Dbxref=PMID:12391161,PMID:15358775	
P08588	UniProtKB	Mutagenesis	476	476	.	.	.	Note=Partial loss of interaction with GOPC. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15358775;Dbxref=PMID:15358775	
P08588	UniProtKB	Mutagenesis	477	477	.	.	.	Note=Loss of interaction with GOPC. V->A%2CF%2CL%2CI%2CM;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12391161,ECO:0000269|PubMed:15358775;Dbxref=PMID:12391161,PMID:15358775	
P08588	UniProtKB	Mutagenesis	477	477	.	.	.	Note=Loss of interaction with RAPGEF2. Abolishes agonist-induced Ras activation. V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12391161,ECO:0000269|PubMed:15358775;Dbxref=PMID:12391161,PMID:15358775	
P08588	UniProtKB	Helix	205	208	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LSQ	
P08588	UniProtKB	Helix	209	211	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LSQ	
P08588	UniProtKB	Helix	213	215	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LSQ	
